Publications by authors named "V Perrot"

Claim this Profile
T
Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN study.
Thierry Lebret, Gilles Crehange, Nathalie Pello-Leprince-Ringuet, Valérie Perrot, Jérôme Rigaud

Ther Adv Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor-based Combination Therapy in Patients with Metastatic Renal Cell Carcinoma.
Laurence Albiges, Thomas Powles, Anand Sharma, Balaji Venugopal, Jens Bedke, Valerie Perrot

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near-adult height outcomes in patients treated with rhIGF-1 for severe growth failure: real-world IGFD Registry data.
Marta Ramon-Krauel, Michel Polak, Mohamad Maghnie, Joachim Woelfle, Caroline Sert, Valérie Perrot

J Clin Endocrinol Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in Europe.
Emmanuelle Kaltenbach, Ana Maria Rodriguez-Leboeuf, Patrick Cabri, Mickael Henry-Szatkowski, Mehmet Inceer, Valérie Perrot

Adv Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan.
Yu-Chieh Tsai, Jian-Ri Li, Kun-Yuan Chiu, Po-Jung Su, Yu-Li Su, Valérie Perrot

J Formos Med Assoc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis